All about you News from the international ophthalmic industry

Silmo Singapore´s first edition kept its promises

Silmo Singapore, ASEAN Optical Fair, was held from 12 to 14 April 2023 at Suntec Singapore Exhibition and Convention Centre. Jointly organized by Silmo International and MP Singapore, the show welcomed over 250 international a nd local brands from over 15 countries representing most product families and ranges in the optics and eyewear industry. 2175 professional visitors, optometrists, dispensing opticians and buying groups had the opportunity to browse the latest eyewear, optical products and technologies. With 50% of its attendance from overseas, Silmo Singapore first edition confirms its ambition to become the new business meeting place in Southeast Asia. Top five of the 44 represented countries were Malaysia, China, Australia, Vietnam and Indonesia.

Augmented reality eyeglasses provide comfort for hearing-impaired and multi-language users

Hearing loss compensation and spoken language translation can now be provided using augmented reality (AR) eyeglasses from Beijing LLVision Technology. The glasses display voice translations in text on the lenses in real time. LLVision employs automatic speech recognition technology and artificial intelligence to create, stream and display voice translation in milliseconds. The computer chip integrated in the legs of the glasses translates voice input into text data. The glasses connect wireless to a smartphone app that handles user authentication.

According to the World Health Organization, about 1.5 billion people (nearly 20% of the global population) live with hearing loss – a number that could rise to 2.5 billion by 2050. Another trend is the growing need for international communication. The LEION Hey glasses can enable individuals to cope with both scenarios.

HCP Cureblindness and SightLife join forces

HCP Cureblindness and SightLife International, leading global eye health nonprofits, announced they have joined forces as one organization to make a greater impact in eye care worldwide. Effective immediately, HCP Cureblindness will acquire the SightLife International Program, the global division of the broader SightLife organization, with full integration of systems, programs, and brand to come over the next twelve months. This transition marks the next step of an ever-growing relationship between the two organizations. For 13 years, HCP Cureblindness and SightLife International have collaborated on multiple projects in clinical training, eye bank development, advocacy and prevention in Nepal and Ethiopia.

EssilorLuxottica unveils four-year clinical trial results of its Essilor Stellest lens at ARVO

EssilorLuxottica presented the four-year clinical trial results of its myopia control Essilor Stellest lens for the first time at the 2023 ARVO annual meeting in New Orleans, United States. The findings show that Essilor Stellest lenses continue to exhibit strong efficacy in slowing myopia progression and axial eye elongation in children in the fourth year. The study assessed the four-year increase of myopia and axial eye length of children who wore spectacle lenses with highly aspherical lenslets (HAL). Essilor Stellest lenses are based on the optical design of HAL lenses. The key findings from the study include: HAL lenses saved more than one and a quarter dioptres of myopia on average over four years. Myopia progression and axial eye elongation in children wearing HAL lenses was slower compared to a modelled control single vision lens group. HAL lenses remain effective in slowing myopia progression and axial eye elongation in older children (11-16 y.o.) in the fourth year.

Source:EuropeanPatentOffice2023